Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
OPTIMISATION OF MOLECULAR ASSA...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
Detalles Bibliográficos
Main Authors:
Sumner-Jones, S
,
McCormick, D
,
Coles, R
,
Pringle, I
,
McLachlan, G
,
Collie, D
,
Vrettou, C
,
Davies, J
,
Alton, E
,
Gill, DR
,
Hyde, S
Formato:
Journal article
Publicado:
2009
Existencias
Descripción
Títulos similares
Staff View
Títulos similares
3-STEP TAQMAN RT-PCR: ULTIMATE MESSENGER RNA DETECTION SENSITIVITY FOR CF GENE THERAPY CLINICAL TRIALS
por: McCormick, D, et al.
Publicado: (2009)
Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes.
por: Davies, L, et al.
Publicado: (2008)
EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
por: Davies, J, et al.
Publicado: (2009)
REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
por: Alton, E, et al.
Publicado: (2012)
Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
por: Alton, E, et al.
Publicado: (2012)